Navigation Links
Varian Medical Systems to Exhibit Cancer Treatment and X-ray Imaging Technologies at China Med Exhibition

Varian to showcase products ranging from treatment planning software for radiation therapy to flat panel detectors for filmless X-ray imaging

BEIJING, March 16 /PRNewswire-FirstCall/ -- Varian Medical Systems, Inc. (NYSE: VAR) will showcase the full spectrum of the company's cancer treatment and X-ray imaging products, including some made available for the first time in China, at the upcoming China Med 21st International Medical Instruments and Equipment Exhibition in Beijing from March 19-21.

Varian will exhibit:

  • The Clinac iX medical linear accelerator, a radiation therapy machine that was introduced into China last year. This treatment machine incorporates a three-dimensional X-ray imager to improve tumor targeting. It can also be upgraded to deliver RapidArc(TM) radiotherapy, which enables doctors to deliver highly-precise image-guided radiotherapy treatments two to eight times faster than was previously possible.
  • Varian's market-leading medical software products, including Eclipse(TM) radiotherapy treatment planning software and ARIA(R) cancer treatment management software.
  • The GammaMedplus(TM) afterloader, a machine for delivering brachytherapy, which is a way of treating cancer by placing tiny radiation sources directly into a targeted tumor.
  • A broad array of X-ray tubes and the company's PaxScan(R) line of flat-panel digital X-ray image detectors, which are used for filmless imaging in medical, dental, and other applications.

"Varian is committed to offering customers the largest selection of X-ray tubes and digital image detectors to serve in a broad range of applications," said Hsiao-Li Pan, manager of Varian's X-ray products distribution business in China. "We will exhibit a variety of X-ray tubes, including one capable of completing a full CT (computed tomography) scan in half a second."

"Varian is pleased to be showcasing its radiotherapy and X-ray products at China Med this year and to be expanding its operations in China," said Ling Zhang, Varian's marketing manager in Beijing, where the company manufactures radiotherapy machines and provides clinical training for medical professionals who treat cancer. Varian's facility in Beijing is also gearing up to manufacture X-ray tubes.

The China Med exhibition will be take place at the China International Exhibition Center in Beijing from March 19-21, 2009.

About Varian Medical Systems

Varian Medical Systems, Inc., of Palo Alto, California, is the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy, and brachytherapy. The company supplies informatics software for managing comprehensive cancer clinics, radiotherapy centers and medical oncology practices. Varian is a premier supplier of tubes and digital detectors for X-ray imaging in medical, scientific, and industrial applications and also supplies X-ray imaging products for cargo screening and industrial inspection. Varian Medical Systems employs approximately 5,100 people who are located at manufacturing sites in China, North America and Europe and in its 60 sales and support offices around the world. For more information, visit our website:


Simplified Chinese:

Traditional Chinese:

    Ling Zhang, M.D.                      Meryl Ginsberg
    Varian Medical Systems, China         Varian Medical Systems, U.S.
    Tel: +86-10-8785 8800                 Tel: 650-424-6444       

SOURCE Varian Medical Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Access Pharmaceuticals Announces Positive ProLindac(TM) Phase 2 Ovarian Cancer Clinical Trial Results
2. Pivotal Data Published For First Biomarker Combination Test to Determine Risk of Ovarian Cancer in Women Who Present With Pelvic Mass
3. A Milestone in Cancer Genetics: deCODE Discovers First Common Genetic Variants Affecting the Risk of Many Types of Cancer
4. Bavarian Nordic Reports Successful Safety Data From Phase II Study With IMVAMUNE(R)
5. Sunesis Pharmaceuticals Presents Clinical Trial Data of Voreloxin in Patients with Acute Myeloid Leukemia and Ovarian Cancer at the Chemotherapy Foundation Symposium
6. Bavarian Nordic Announces Positive Mature Phase II Results From Newly Acquired Prostate Cancer Vaccine
7. AEterna Zentaris Reaches 2nd Stage of Patient Recruitment for Phase 2 Trial in Ovarian Cancer with the Innovative LHRH Receptor Targeted Conjugate, AEZS-108
8. Experts Assert That Varian Technologies Deliver Speed and Clinical Accuracy in Treating Cancer Patients
9. deCODE and Radboud University Discover Common Variants in the Human Genome Conferring Risk of Bladder Cancer
10. 96-Well Filtration Plate From Varian, Inc. Improves Sensitivity and Precision for Trace Bio-Analysis by LC/MS
11. Variant of Mad Cow Disease May Be Transmitted by Blood Transfusions, According to Animal Study
Post Your Comments:
(Date:6/24/2016)... Research and Markets has announced the ... Tests" report to their offering. ... The World Market for Companion Diagnostics covers the ... analysis in the report includes the following: ... Kits) by Region (N. America, EU, ROW), 2015-2020 , ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
(Date:6/23/2016)... June 23, 2016 Research and Markets ... Market - Forecast to 2022" report to their offering. ... method for the patients with kidney failure, it replaces the ... from the patient,s blood and thus the treatment helps to ... chloride in balance. Increasing number of ESRD ...
Breaking Medicine Technology:
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... Austin residents ... the American College of Mohs Surgery and to Dr. Russell Peckham for medical and ... highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic Surgery completed ...
(Date:6/25/2016)... , ... June 25, 2016 , ... As a lifelong ... Cum Laude and his M.D from the David Geffen School of Medicine at UCLA. ... to Los Angeles to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai ...
(Date:6/24/2016)... ... , ... A recent article published June 14 on E Online ... on to state that individuals are now more comfortable seeking to undergo not only ... calf and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) ...
(Date:6/24/2016)... Dallas, Texas (PRWEB) , ... June 24, 2016 ... ... 12th International Conference and Scientific Sessions in Dallas that it will receive two ... Announcement of the grants came as PHA marked its 25th anniversary by recognizing ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
Breaking Medicine News(10 mins):